Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin effects on brown adipose tissue and metabolism in overweight prediabetic men
NL-OMON44534Phase 4Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sitagliptin in prediabetes, sponsored by Merck & Co. Primary endpoint: Brown adipose tissue activity. Started Feb 2015; status: active, not recruiting.
02
Drugs
sitagliptin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NL-OMON44534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44534.